Cellular immune responses and lymphocyte populations in chronic hepatitis. 1979

A Pár, and G Bajtai, and K Barna, and M Ambrus, and M Kovács, and M Balázs, and I Palka, and I Szalók

Cellular immune responsiveness was examined in chronic persistent hepatitis, chronic active hepatitis and alcoholic liver disease by the use of the lymphocyte transformation test in response to PHA and to allogenic liver mitochondria, inhibition of leukocyte migration, delayed-type skin tests and non-immunospecific granulocyte function tests. Lymphocyte markers, E and EAC rosette forming cells were used for the study of lymphocyte populations. The results have confirmed that the T-cell borne cell-mediated immune function is impaired in chronic active hepatitis, as also in a number of cases of chronic persistent hepatitis.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008930 Mitochondria, Liver Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4) Liver Mitochondria,Liver Mitochondrion,Mitochondrion, Liver
D010835 Phytohemagglutinins Mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture. Kidney Bean Lectin,Kidney Bean Lectins,Lectins, Kidney Bean,Phaseolus vulgaris Lectin,Phaseolus vulgaris Lectins,Phytohemagglutinin,Hemagglutinins, Plant,Lectin, Kidney Bean,Lectin, Phaseolus vulgaris,Lectins, Phaseolus vulgaris,Plant Hemagglutinins
D002464 Cell Migration Inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated LEUKOCYTES or MACROPHAGES. Specific CELL MIGRATION ASSAYS have been developed to estimate levels of migration inhibitory factors, immune reactivity against tumor-associated antigens, and immunosuppressive effects of infectious microorganisms. Chemotaxis Inhibition,Chemotaxis Inhibitions,Inhibition, Chemotaxis,Inhibitions, Chemotaxis
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females

Related Publications

A Pár, and G Bajtai, and K Barna, and M Ambrus, and M Kovács, and M Balázs, and I Palka, and I Szalók
February 1978, Journal of the National Cancer Institute,
A Pár, and G Bajtai, and K Barna, and M Ambrus, and M Kovács, and M Balázs, and I Palka, and I Szalók
November 2008, Journal of viral hepatitis,
A Pár, and G Bajtai, and K Barna, and M Ambrus, and M Kovács, and M Balázs, and I Palka, and I Szalók
July 1994, European journal of immunology,
A Pár, and G Bajtai, and K Barna, and M Ambrus, and M Kovács, and M Balázs, and I Palka, and I Szalók
September 1986, Journal of Korean medical science,
A Pár, and G Bajtai, and K Barna, and M Ambrus, and M Kovács, and M Balázs, and I Palka, and I Szalók
January 1975, Scandinavian journal of immunology,
A Pár, and G Bajtai, and K Barna, and M Ambrus, and M Kovács, and M Balázs, and I Palka, and I Szalók
July 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
A Pár, and G Bajtai, and K Barna, and M Ambrus, and M Kovács, and M Balázs, and I Palka, and I Szalók
January 1990, Progress in clinical and biological research,
A Pár, and G Bajtai, and K Barna, and M Ambrus, and M Kovács, and M Balázs, and I Palka, and I Szalók
January 1975, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
A Pár, and G Bajtai, and K Barna, and M Ambrus, and M Kovács, and M Balázs, and I Palka, and I Szalók
October 2011, Journal of viral hepatitis,
A Pár, and G Bajtai, and K Barna, and M Ambrus, and M Kovács, and M Balázs, and I Palka, and I Szalók
January 1978, Clinical immunology and immunopathology,
Copied contents to your clipboard!